HIF-1α Transgenic Bone Marrow Cells Can Promote Tissue Repair in Cases of Corticosteroid-Induced Osteonecrosis of the Femoral Head in Rabbits

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Ding, Hao ^a   Gao, You Shui ^a   Hu, Chen ^b   Wang, Yang ^a   Wang, Chuan Gui ^b   Yin, Ji Min ^a   Sun, Yuan ^a   Zhang, Chang Qing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALIZARIN RED S; ALKALINE PHOSPHATASE; CORTICOSTEROID; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; METHYLPREDNISOLONE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BONE DEVELOPMENT; BONE MARROW TRANSPLANTATION; BONE REGENERATION; CELL DIFFERENTIATION; CELL THERAPY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMUR HEAD NECROSIS; GENE EXPRESSION; GENETIC TRANSFECTION; IN VITRO STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN SECRETION; RABBIT; TISSUE REPAIR; TRANSGENICS;

ADRENAL CORTEX HORMONES; ALKALINE PHOSPHATASE; ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; BONE REGENERATION; CELL DIFFERENTIATION; CELL ENGINEERING; CELLS, CULTURED; FEMUR HEAD; FEMUR HEAD NECROSIS; GENE EXPRESSION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; RABBITS; TRANSGENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84877674887     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063628     Document Type: Article

References (42)

1. Atsumi T, Kuroki Y, (1992) Role of impairment of blood supply of the femoral head in the pathogenesis of idiopathic osteonecrosis. Clin Orthop Relat Res 277: 22-30.
2. Jones JP Jr, (1993) Fat embolism, intravascular coagulation, and osteonecrosis. Clin Orthop Relat Res 292: 294-308.
3. Chiu KH, Shen WY, Ko CK, Chan KM, (1997) Osteonecrosis of the femoral head treated with cementless total hip arthroplasty: a comparison with other diagnoses. J Arthroplasty 12: 683-688.
4. Yoon TR, Song EK, Rowe SM, Park CH, (2001) Failure after core decompression in osteonecrosis of the femoral head. Int Orthop 24: 316-318.
5. Lieberman JR, Berry DJ, Mont MA, Aaron RK, Callaqhan JJ, et al. (2003) Osteonecrosis of the hip: management in the 21st century. Instr Course Lect 52: 337-355.
6. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Haberbosch W, et al. (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355: 1210-1221.
7. Dadon-Nachum M, Sadan O, Srugo I, Melamed E, Offen D, (2011) Differentiated mesenchymal stem cells for sciatic nerve injury. Stem Cell Rev 7: 664-671.
8. Yang Y, Hallgrimsson B, Putnins EE, (2011) Craniofacial defect regeneration using engineered bone marrow mesenchymal stromal cells. J Biomed Mater Res A 99: 74-85.
9. Sun Y, Feng Y, Zhang C, (2009) The effect of bone marrow mononuclear cells on vascularization and bone regeneration in steroid-induced osteonecrosis of the femoral head. Joint Bone Spine 76: 685-690.
10. Gangji V, Hauzeur JP, Matos C, De Maertelaer V, Toungouz M, et al. (2004) Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A. Pilot study. J Bone Joint Surg Am 86: 1153-1160.
11. Tzaribachev N, Vaegler M, Schaefer J, Reize P, Rudert M, et al. (2008) Mesenchymal stromal cells: A novel treatment option for steroid-induced avascular osteonecrosis. Isr Med Assoc J 10: 232-234.
12. Yan Z, Hang D, Guo C, Chen Z, (2009) Fate of mesenchymal stem cells transplanted to osteonecrosis of femoral head. J orthop Res 27: 442-446.
13. Beckermann BM, Kallifatidis G, Groth A, Frommhold D, Apel A, et al. (2008) VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Br J Cancer 99: 622-631.
14. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, et al. (2004) Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109: 1543-1549.
15. Riddle RC, Khatri R, Schipani E, Clemens TL, (2009) Role of hypoxia-inducible factor-1a in angiogenic-osteogenic coupling. J Mol Med (Berl) 87: 583-90.
16. Zou D, Han W, You S, Ye D, Wang L, et al. (2011) In vitro study of enhanced osteogenesis induced by HIF-1a-transduced bone marrow stem cells. Cell Prolif 44: 234-243.
17. Keith B, Simon MC, (2007) Hypoxia-inducible factors, stem cells, and cancer. Cell 129: 465-472.
18. Qin L, Zhang G, Sheng H, Yeung KW, Yeung HY, et al. (2006) Multiple imaging modalities in evaluation of experimental osteonecrosis induced by a combination of lipopolysaccharide and methylprednisolone. Bone 39: 863-871.
19. Gangji V, De Maertelaer V, Hauzeur JP, (2011) Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: five year follow-up of a prospective controlled study. Bone 49: 1005-1009.
20. Tang TT, Lu B, Yue B, Xie XH, Xie YZ, et al. (2007) Treatment of osteonecrosis of the femoral head with hBMP-2-gene-modified tissue engineered bone in goat. J Bone Joint Surg Br 89: 127-132.
21. Wen Q, Ma L, Chen YP, Yang L, Luo W, et al. (2008) Treatment of avascular necrosis of the femoral head by hepatocyte growth factor-transgenic bone marrow stromal stem cells. Gene Ther 15: 1523-35.
22. Hang D, Wang Q, Guo C, Chen Z, Yan Z, (2012) Treatment of osteonecrosis of the femoral head with VEGF165 transgenic bone marrow mesenchymal stem cells in mongrel dogs. Cells Tissues Organs 195: 495-506.
23. Mazumdar J, Dondeti V, Simon MC, (2009) Hypoxia-inducible factors in stem cells and cancer. J Cell Mol Med 13: 4319-4328.
24. Wan C, Shao J, Gilbert SR, Riddle RC, Long F, et al. (2010) Role of HIF-1alpha in skeletal development. Ann N Y Acad Sci 1192: 322-326.
25. Shomento SH, Wan C, Cao X, Faugere MC, Bouxsein ML, et al. (2010) Hypoxia-inducible factors 1alpha and 2alpha exert both distinct and overlapping functions in long bone development. J Cell Biochem 109: 196-204.
26. Nagano M, Kimura K, Yamashita T, Ohneda K, Nozawa D, et al. (2010) Hypoxia responsive mesenchymal stem cells derived from human umbilical cord blood are effective for bone repair. Stem Cells Dev 19: 1195-1210.
27. Ferrara N, (1999) Molecular and biological properties of vascular endothelial growth factor. J Mol Med (Berl) 77: 527-543.
28. Dai Y, Xu M, Wang Y, Pasha Z, Li T, et al. (2007) HIF-1a induced-VEGF overexpression in bone marrow stem cells protects cardiomyocytes against ischemia. J Mol Cell Cardiol 42: 1036-1044.
29. Thurston G, Rudge JS, Loffe E, Zhou H, Ross L, et al. (2000) Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6: 460-463.
30. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604-4613.
31. Ceradini DJ, Kullkarni AR, Callaghan MJ, Tepper OM, Bastidas N, et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10: 858-864.
32. kelly BD, Hackett SF, Hirota K, Oshima Y, Cai Z, et al. (2003) Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93: 1074-1081.
33. Qu D, Li J, Li Y, Gao Y, Zuo Y, et al. (2011) Angiogenesis and osteogenesis enhanced by bFGF ex vivo gene therapy for bone tissue engineering in reconstruction of calvarial defects. J Biomed Mater Res A 96: 543-551.
34. Fukuhara S, Sako K, Noda K, Zhang J, Minami M, et al. (2010) Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol 25: 387-396.
35. Ziche M, Maglione D, Ribatti D, Morbidelli L, Lago CT, et al. (1997) Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest 76: 517-531.
36. Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, et al. (2010) Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141: 1667-1674.
37. Mayr-Wohlfart U, Waltenberger J, Hausser H, Kessler S, Gunther KP, et al. (2002) Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 30: 472-477.
38. Mayer H, Bertram H, Lindenmaier W, Korff T, Weber H, et al. (2005) Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. J Cell Biochem 95: 827-839.
39. Zou D, Zhang Z, Zhang K, Ye D, Han W, et al. (2012) Blood vessel formation in the tissue-engineered bone with the constitutively active form of HIF-1a mediated BMSCs. Biomaterials 33: 2097-2108.
40. Loinard C, Ginouves A, Vilar J, Cochain C, Zouggari Y, et al. (2009) Inhibition of prolyl hydroxylase domain proteins promotes therapeutic revascularization. Circulation 120: 50-59.
41. Botusan IR, Sunkari VG, Savu O, Catrina AI, Grunler J, et al. (2008) Stabilization of HIF-1alpha is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci USA 105: 19426-19431.
42. Takaku M, Tomita S, Kurobe H, Kihira Y, Morimoto A, et al. (2012) Systemic preconditioning by a prolyl hydroxylase inhibitor promotes prevention of skin flap necrosis via HIF-1-induced bone marrow-derived cells. PLoS ONE 7: e42964 doi: 10.1371/journal.pone.0042964.